Phosphorylated RB Promotes Cancer Immunity by Inhibiting NF-κB Activation and PD-L1 Expression
- 6 December 2018
- journal article
- research article
- Published by Elsevier BV in Molecular Cell
- Vol. 73 (1), 22-35.e6
- https://doi.org/10.1016/j.molcel.2018.10.034
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81702374)
- Mayo Clinic
This publication has 46 references indexed in Scilit:
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in CancerThe New England Journal of Medicine, 2012
- Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunityCurrent Opinion in Immunology, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- E2f binding-deficientRb1protein suppresses prostate tumor progression in vivoProceedings of the National Academy of Sciences of the United States of America, 2010
- Phosphorylation-induced Conformational Changes in the Retinoblastoma Protein Inhibit E2F Transactivation Domain BindingJournal of Biological Chemistry, 2010
- The Double Bromodomain Proteins Brd2 and Brd3 Couple Histone Acetylation to TranscriptionMolecular Cell, 2008
- Murine Cell Lines Derived from Pten Null Prostate Cancer Show the Critical Role of PTEN in Hormone Refractory Prostate Cancer DevelopmentCancer Research, 2007
- Inhibition of Tumor Necrosis Factor-α-induced Nuclear Translocation and Activation of NF-κB by DehydroxymethylepoxyquinomicinOnline Journal of Public Health Informatics, 2002
- Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte ActivationThe Journal of Experimental Medicine, 2000
- The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory elementCell, 1989